Paul Quinlan

Paul Quinlan

General CounselatOruka Therapeutics· In proxies 2024–2025

Pay in FY2025Oruka Therapeutics stock +56.3% the same year

Paul Quinlan was paid $2.3M in FY2025 (Dec). Oruka Therapeutics stock rose 56.3% that year.

Pay$100 in the stock at the end of FY24 → $156
Pay is from the Summary Compensation Table of each Oruka Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oruka TherapeuticsPublic company · 2 yr
    • General Counsel2024 – Present · 2 yrStock in role +775%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?